MAPT subhaplotypes and risk for progressive supranuclear palsy and tau pathology

Takeaway

  • Microtubule-associated protein tau (MAPT) H1 haplotypes are associated with an increased risk for progressive supranuclear palsy (PSP), but a subset of haplotypes may be the driving force behind this association and also impact severity of tau pathology.

Why this matters

  • These results lead to better understanding of the contribution of individual MAPT H1 subhaplotypes to PSP, with the potential to act as biomarkers for disease onset and progression.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.